Repeated acute testing of anticonvulsant drugs in amygdala kindled rats: Increase in anticonvulsant but decrease in adverse effect potential

Epilepsia

Volumn 41, Issue 5, 2000, Pages 516-528

  Löscher, Wolfgang ^a   Fiedler, Mia ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Antiepileptic drugs; Carbamazepine; Epilepsy; Kindling; Phenobarbital; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; VALPROIC ACID;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENCY; EPILEPTIC DISCHARGE; FEMALE; KINDLING; NONHUMAN; PRIORITY JOURNAL; RAT; SEASONAL VARIATION; SEIZURE THRESHOLD;

EID: 0034061673     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb00204.x     Document Type: Article

References (40)

1. Löscher W. Animal models of epilepsy and epileptic seizures. In: Eadie MJ, Vajda F, eds. Antiepileptic drugs: handbook of experimenial pharmacology. Berlin: Springer, 1999:19-62.
2. Löscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 1988;2:145-81.
3. Löscher W, Schmidt D. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 1994;17:95-134.
4. Mace JA, Burnham WM. The effect of repeated seizures on anticonvulsant drug response in the kindling model. Electroencephalogr Clin Neumphysiol 1987;67:171-5.
5. Albright PS, Burnham WM. Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat. Epilepsia 1980;21:681-9.
6. Weiss SRB, Clark M, Rosen JB, Smith MA, Post RM. Contingent tolerance to the anticonvulsant effects of carbamazepine: relationship to loss of endogenous adaptive mechanisms. Brain Res Rev 1995;20:305-25.
7. Löscher W, Fiedler M. The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VII. Seasonal influences on anticonvulsant drug actions in mouse models of generalized seizures. Epilepsy Res 2000;38:231-48.
8. Löscher W, Hönack D. Responses to NMDA receptor antagonists altered by epileptogenesis. Trends Pharmacol Sci 1991;12:52.
9. Hönack D, Löscher W. Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia 1995;36: 763-71.
10. Löscher W. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog Neurobiol 1998;54:721-41.
11. Matagne A, Klitgaard H. Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man. Epilepsy Res 1998;31:59-71.
12. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press, 1986.
13. Freeman FG, Jarvis MF. The effect of interstimulation interval on the assessment and stability of kindled seizure threshold. Brain Res Bull 1981;7:629-33.
14. Racine RJ. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972;32:281-94.
15. Löscher W. Rapid determination of valproate sodium in serum by gas liquid chromatography. Epilepsia 1977;18:225-7.
16. Löscher W, Göbel W. Consecutive gas Chromatographic determination of phenytoin, phenobarbital, primidone, phenylethylmalondiamide, carbamazepine, trimethadione, dimethadione, ethosuximide and valproate from the same serum specimen. Epilepsia 1978;19:463-73.
17. Frey H-H, Löscher W. Pharmacokinetics of carbamazepine in the dog. Arch Int Pharmacodyn Ther 1980;243:180-91.
18. Frey H-H, Löscher W, Reiche R, Schultz D. Anticonvulsant effect of primidone in the gerbil: time course and significance of the active metabolites. Pharmacology 1984;28:329-35.
19. Fiedler M. Saisonale Einflüsse auf Krampferregbarkeit und die Wirkung von Standardantiepileptika. Doctoral thesis. Tierärztliche Hochschule Hannover, 1993.
20. Pinel JPJ, Rovner LI. Electrode placement and kindling-induced experimental epilepsy. Exp Neurol 1978;58:335-46.
21. Sayin Ü, Rutecki PA, Sutula TP. Spontaneous seizures associated with long-term reduction of inhibition in the dentate gyrus and CA3 of kindled rats. Soc Neurosci Abstr 1998;24:1205.
22. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998;39:5-17.
23. Kim CK, Pinel JPJ, Hudda MM, Wong DJ, Yung A. Tolerance to the anticonvulsant effects of phenobarbital, trimethadione, and clonazepam in kindled rats: cross tolerance to carbamazepine. Pharmacol Biochem Behav 1992;41:115-20.
24. Mana MJ, Kim CK, Pinel JPJ. Tolerance to the anticonvulsant effects of carbamazepine, diazepam, and sodium valproate in kindled rats. Pharmacol Biochem Behav 1992;41:109-13.
25. Pinel JPJ, Kim CK, Mana MJ. Contingent tolerance to the anticonvulsant effects of drugs on kindled convulsions. In: Wada JA, ed. Kindling 4. New York: Plenum Press, 1990:283-94.
26. Mucha RF, Pinel JPJ. Postseizure inhibition of kindled seizures. Exp Neurol 1977;54:266-82.
27. Engel JJ, Ackermann RF, Caldecott-Hazard S, Kuhl DE. Epileptic activation of antagonistic systems may explain paradoxical features of experimental and human epilepsy: a review and hypothesis. In: Wada JA, ed. Kindling 2. New York: Raven Press, 1981: 193-217.
28. Goddard GV, Dragunov M, Maru E, Macleod EK: Kindling and the forces that oppose it. In: Doane BK, Livingston KE, eds. The limbic system: functional organization and clinical disorders. New York: Raven Press, 1986:95-108.
29. Burnham WM, Cottrell GA. The GABA hypothesis of kindling. In: Wada JA, ed. Kindling 4. New York: Plenum Press, 1990:127-40.
30. Löscher W, Hönack D. The effect of interstimulation interval on the assessment of anticonvulsant drug potency in fully kindled rats. Epilepsy Res 1990;7:182-96.
31. Goudie AJ. Behavioral techniques for assessing drug tolerance and sensitization. In: Boulton AA, Baker GB, Greenshaw AJ, eds. Neuromethods vol. 13: Psychopharmacology. Clifton, NJ: Humana Press, 1989:565-622.
32. Le Moal M. Mesocorticolimbic dopaminergic neurons. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The fourth generation of progress. New York: Raven Press, 1995:283-94.
33. Hönack D, Löscher W. Amygdala-kindling as a model for chronic efficacy studies on antiepileptic drugs: experiments with carbamazepine. Neuropharmacology 1989;28:599-610.
34. Löscher W, Hönack D. Comparison of the anticonvulsant efficacy of primidone and phenobarbital during chronic treatment of amygdala-kindled rats. Eur J Pharmacol 1989;162:309-22.
35. Löscher W, Fisher JE, Nau H, Hönack D. Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment. J Pharmacol Exp Ther 1989;250:1067-78.
36. Pórszász J, Wórum I. Seasonal variations of electroshock seizure susceptibility in the rat. Acta Physiol Acad Sci Hung 1971;40:93-100.
37. Champney TH, Peterson SL. Circadian, seasonal, pineal, and melatonin influences on epilepsy. In: Yu H-S, Reiter RJ, eds. Melatonin: biosynthesis, physiological effects, and clinical applications. Boca Raton: CRC Press, 1993:477-94.
38. Wlaz P, Löscher W. The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. V. Lack of seasonal influences on amygdala kindling in rats. Epilepsy Res 1993;16:131-6.
39. Löscher W, Fiedler M. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VI. Seasonal influences on maximal electroshock and pentylenetetrazol seizure thresholds. Epilepsy Res 1996;25:3-10.
40. Ebert U, Rundfeldt C. Lehmann H. Löscher W. Characterization of phenytoin-resistant rats, a new model of drug-resistant partial epilepsy: influence of experimental and environmental factors. Epilepsy Res 1999;33:199-215.